Intravenous Methylprednisolone Treatment of Ocular Myasthenia Gravis

Update Item Information
Identifier 20060228_nanos_posters_087.pdf
Title Intravenous Methylprednisolone Treatment of Ocular Myasthenia Gravis
Creator Warden, Kara F; Mizrachi, I Ben-Bassat; Cornblath, Wayne T
Subject ocular myasthenia gravis, intravenous methlyprednisolone, diplopia, ptosis
Description Ocular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment consists of either Mestinon or immunosuppressive agents. Many patients with ocular myasthenia gravis are elderly and long term prednisone treatment is fraught with complications. Other immunosuppressive drugs are expensive, take a long time to work or have other complications.
Date 2006-02-28
Language eng
Format application/pdf
Format Creation application/pdf
Type Text
Source 2006 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2006: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6b59r53
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Secondary Jonathan D. Trobe, MD; William F. Hoyt, MD
Setname ehsl_novel_nam
ID 181141
Reference URL https://collections.lib.utah.edu/ark:/87278/s6b59r53
Back to Search Results